Atea Pharmaceuticals, Inc. (AVIR)
USD 2.98
(-0.33%)
USD 2.98
(-0.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -85.39 Million | -120.98 Million | -87 Million | 296.73 Million | -12.81 Million | -7.9 Million |
| Net Income | -135.95 Million | -115.9 Million | 121.19 Million | -10.94 Million | -14.03 Million | -9.06 Million |
| Depreciation & Amortization | 416 Thousand | 260 Thousand | 29 Thousand | 19 Thousand | 17 Thousand | 17 Thousand |
| Deferred income taxes | -48.55 Million | - | -29.39 Million | -13.79 Million | -501 Thousand | - |
| Stock-based compensation | 49.42 Million | 46.71 Million | 39.62 Million | 7.45 Million | 624 Thousand | 414 Thousand |
| Change in working capital | 16.16 Million | -46.58 Million | -247.84 Million | 300.2 Million | 579 Thousand | 725 Thousand |
| Other non-cash items | 33.11 Million | -5.46 Million | 29.39 Million | 13.79 Million | 501 Thousand | 538 Thousand |
| Investing Cash Flow | 40.3 Million | -455.41 Million | -4000.00 | -26 Thousand | -2000.00 | -12 Thousand |
| Investments in PPE | - | -1.94 Million | -4000.00 | -26 Thousand | -2000.00 | -12 Thousand |
| Acquisitions | - | 453.46 Thousand | - | - | - | - |
| Investment purchases | -562.36 Million | -545.35 Million | - | - | - | - |
| Sales/Maturities of investments | 602.66 Million | 91.88 Million | - | - | - | - |
| Other Investing Activities | 40.3 Thousand | -453.46 Thousand | - | - | - | - |
| Financing Cash Flow | 257 Thousand | 370 Thousand | 1.46 Million | 531.74 Million | -15 Thousand | 27.48 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 257 Thousand | 230 Thousand | 1.46 Million | 317.63 Million | -15 Thousand | 124 Thousand |
| Other Financing Activities | 257.00 | 140 Thousand | 1465.00 | 214.11 Million | -15 Thousand | 27.35 Million |
| Accounts receivables | - | - | - | -5.81 Million | - | - |
| Accounts payables | 1.7 Million | -1.98 Million | 10.28 Million | -488 Thousand | 157 Thousand | -90 Thousand |
| Inventory | - | - | - | 5.14 Million | - | - |
| Other working capital | 14.46 Million | -44.6 Million | -258.13 Million | 301.36 Million | 422 Thousand | 815 Thousand |
| Cash at beginning of period | 188.46 Million | 764.68 Million | 850.22 Million | 21.76 Million | 34.59 Million | 15.03 Million |
| Cash at end of period | 143.82 Million | 188.65 Million | 764.68 Million | 850.22 Million | 21.76 Million | 34.59 Million |
| Capital Expenditure | - | -1.94 Million | -4000.00 | -26 Thousand | -2000.00 | -12 Thousand |
| Effect of forex changes on cash | 198 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -44.63 Million | -576.02 Million | -85.54 Million | 828.45 Million | -12.83 Million | 19.56 Million |
| Free Cash Flow | -85.39 Million | -122.92 Million | -87 Million | 296.7 Million | -12.81 Million | -7.92 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -40.52 Million | -63.16 Million | -135.95 Million | -39.16 Million | -33.14 Million | -28.18 Million |
| Depreciation & Amortization | 104 Thousand | 104 Thousand | 416 Thousand | 104 Thousand | 104 Thousand | 104 Thousand |
| Deferred income taxes | - | - | -48.55 Million | -8.5 Million | -37.45 Million | -31.88 Million |
| Stock-based compensation | 12.72 Million | 12.58 Million | 49.42 Million | 12.15 Million | 12.38 Million | 12.35 Million |
| Change in working capital | -11.48 Million | 14.1 Million | 16.16 Million | 9.41 Million | 7.38 Million | 3.3 Million |
| Other non-cash items | 25.57 Million | -7.57 Million | 33.11 Million | 4.16 Million | 33.14 Million | 28.18 Million |
| Investing Cash Flow | 124.68 Million | 56.8 Million | 40.3 Million | 27.77 Million | -58.51 Million | 46.56 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -7.26 Million | -167.19 Million | -562.36 Million | -47.23 Million | -205.28 Million | -153.21 Million |
| Sales/Maturities of investments | 131.94 Million | 223.99 Million | 602.66 Million | 75 Million | 146.77 Million | 199.78 Million |
| Other Investing Activities | 124.68 Million | 56.8 Million | 40.3 Thousand | 27.77 Thousand | -58.51 Thousand | 46.56 Thousand |
| Financing Cash Flow | - | 150 Thousand | 257 Thousand | - | 92 Thousand | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 150 Thousand | 257 Thousand | - | 92 Thousand | - |
| Other Financing Activities | - | 150 Thousand | 257.00 | - | 92.00 | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -15.66 Million | 16.88 Million | 1.7 Million | 3.85 Million | -3.56 Million | 3.26 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.18 Million | -2.78 Million | 14.46 Million | 5.55 Million | 10.94 Million | 41 Thousand |
| Cash at beginning of period | 160.91 Million | 143.82 Million | 188.46 Million | 137.88 Million | 213.89 Million | 183.45 Million |
| Cash at end of period | 243.39 Million | 160.91 Million | 143.82 Million | 143.82 Million | 137.88 Million | 213.89 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 198 Thousand | - | 42.87 Million | - |
| Net cash flow / Change in cash | 82.48 Million | 17.08 Million | -44.63 Million | 5.93 Million | -76.01 Million | 30.44 Million |
| Free Cash Flow | -42.2 Million | -39.86 Million | -85.39 Million | -21.83 Million | -17.59 Million | -16.12 Million |
LUG
FEC
GMG
JBNK
0667
ROP